TDOC:CA:TSX-TD Global Healthcare Leaders Index ETF (CAD)

ETF | Others |

Last Closing

CAD 18.98

Change

+0.18 (+0.96)%

Market Cap

CAD 0.08B

Volume

6.02K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.17 (-0.47%)

CAD 6.64B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.18 (+0.64%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.91B
PHYS-U:CA Sprott Physical Gold Trust

+0.08 (+0.35%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.16 (-0.41%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.18 (+0.38%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.14 (+0.52%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.14 (+1.27%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.12 (+0.53%)

CAD 2.78B

ETFs Containing TDOC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.38% 67% D+ 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.38% 67% D+ 62% D
Trailing 12 Months  
Capital Gain 3.72% 26% F 29% F
Dividend Return 2.46% 49% F 36% F
Total Return 6.17% 25% F 26% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.41% 51% F 45% F
Dividend Return 3.61% 49% F 38% F
Total Return 0.19% 31% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 6.09% 75% C 88% B+
Risk Adjusted Return 59.19% 69% C- 68% D+
Market Capitalization 0.08B 58% F 31% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.